7月29日，阿里健康盘中上涨3.21%，报3.54港元，成交额5619万港元。
消息面上，阿里健康旗下医学AI平台"氢离子"近日先后与NEJM、JAMA及BMJ三大全球顶级医学期刊达成内容合作协议，成为国内首个集齐三大医学顶刊全文授权的AI平台，标志着公司在AI医疗领域的内容壁垒进一步加深。此外，公司此前披露FY2026业绩，全年收入342.55亿元人民币，同比增长12.0%，净利润19.36亿元，同比增长35.2%，基本面持续改善。板块方面，同行业京东健康同日上涨4.27%，行业整体情绪偏暖。
阿里健康是阿里巴巴在大健康领域的旗舰平台，主营医药电商、互联网医疗及数字医疗业务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.